| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |